Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Tirzepatide is a dual-action medication that targets both GLP-1 and GIP receptors, which is why clinical trials have shown it producing greater average weight loss than semaglutide alone
If dizziness persists or becomes severe, it is important to consult a healthcare provider
We refer to it as injectable-like results, without the injection
Effects fade when you stop, and chasing permanence with continued high-dose injections is where the safety risk climbs
The usual dosage starts at 0.25 mg per week and can be gradually increased, depending on how you respond to the medication
US$ 23.06
US$ 23.78
US$ 24.49
US$ 25.32
US$ 24.12
US$ 27.40
US$ 24.04
US$ 26.94
